The Kim Jolly Lupus Research Fund was established in memory of Ms Kim Jolly, a young woman who tragically lost her life to Lupus after a long struggle. Initiated by her family, and now carried on in partnership with Lupus Victoria, the leading Lupus patient support organisation, the Kim Jolly Lupus Research Fund has supported lupus research at Monash University for the past ten years, having donated almost $200,000.
Featured post
SCS research and awards news
For all our research and awards news, please visit our news page.
Wednesday, 13 March 2019
Free ISCT workshop for medical, nursing and pharmacy students
A special initiative to Medical, Pharmacy and Nursing students
- Dates: 29 May - 1 June 2019
- Contact: meetings@celltherapysociety.org to register
- Visit website for further information.
CSL Research Acceleration Initiative
Looking to translate your research into life-saving therapies for patients and work with one of the world’s leading biopharmaceutical companies?
CSL, Monash University and Hudson Institute have established a new collaborative initiative to accelerate research across selected therapeutic areas. CSL have committed to fund selected projects across Australia, with up to $500,000 each, for up to 24 months
CSL, Monash University and Hudson Institute have established a new collaborative initiative to accelerate research across selected therapeutic areas. CSL have committed to fund selected projects across Australia, with up to $500,000 each, for up to 24 months
Professor Beverley Vollenhoven inducted into the Victorian Honour Roll of Women for 2019
Congratulations to Professor Beverley Vollenhoven on being inducted into the Victorian Honour Roll of Women for 2019 at an event held last Friday 8 March - which also marked International Women’s Day.
Tuesday, 12 March 2019
Publications for 5 March 2019
Human amnion cells for the prevention of bronchopulmonary dysplasia: a protocol for a phase I dose escalation study. Baker EK, Malhotra A, Lim R, Jacobs SE, Hooper SB, Davis PG, Wallace EM BMJ Open. 2019 Mar 1;9(2):e026265. doi: 10.1136/bmjopen-2018-026265 PMID: 30826799 [PubMed - in process] Free Article
Pharmacological inhibition of protease-activated receptor-2 reduces crescent formation in rat nephrotoxic serum nephritis. Han Y, Tian L, Ma F, Tesch G, Vesey DA, Gobe GC, Lohman RJ, Morais C, Suen JY, Fairlie DP, Nikolic-Paterson DJ. Clin Exp Pharmacol Physiol. 2019 Feb 27. doi: 10.1111/1440-1681.13077. [Epub ahead of print] PMID: 30811624 [PubMed - as supplied by publisher]
Spatiotemporal Gait Characteristics Associated with Cognitive Impairment: A Multicenter Cross-Sectional Study, the Intercontinental "Gait, cOgnitiOn & Decline" Initiative. Beauchet O, Blumen HM, Callisaya ML, De Cock AM, Kressig RW, Srikanth V, Steinmetz JP, Verghese J, Allali G. Curr Alzheimer Res. 2018 Jan 23;15(3):273-282. doi: 10.2174/1567205014666170725125621. PMID: 28745226 [PubMed - indexed for MEDLINE]
Pharmacological inhibition of protease-activated receptor-2 reduces crescent formation in rat nephrotoxic serum nephritis. Han Y, Tian L, Ma F, Tesch G, Vesey DA, Gobe GC, Lohman RJ, Morais C, Suen JY, Fairlie DP, Nikolic-Paterson DJ. Clin Exp Pharmacol Physiol. 2019 Feb 27. doi: 10.1111/1440-1681.13077. [Epub ahead of print] PMID: 30811624 [PubMed - as supplied by publisher]
Spatiotemporal Gait Characteristics Associated with Cognitive Impairment: A Multicenter Cross-Sectional Study, the Intercontinental "Gait, cOgnitiOn & Decline" Initiative. Beauchet O, Blumen HM, Callisaya ML, De Cock AM, Kressig RW, Srikanth V, Steinmetz JP, Verghese J, Allali G. Curr Alzheimer Res. 2018 Jan 23;15(3):273-282. doi: 10.2174/1567205014666170725125621. PMID: 28745226 [PubMed - indexed for MEDLINE]
Subscribe to:
Posts (Atom)